Are Medical Stocks Lagging Bioventus (BVS) This Year?
Consumer Sentiment Just Crashed Below the Recession Threshold. These 3 Defensive Stocks Under $25 Are Built for What Comes Next
Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?
Bioventus Inc. (BVS) Q1 2026 Earnings Call Transcript
Bioventus (BVS) Surpasses Q1 Earnings and Revenue Estimates
Bioventus Reports First Quarter Financial Results
Should Value Investors Buy Bioventus (BVS) Stock?
Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength?
Are Investors Undervaluing Bioventus (BVS) Right Now?
Check-Cap (NASDAQ:MBAI) versus Bioventus (NASDAQ:BVS) Financial Survey
Bioventus (NASDAQ:BVS) vs. Biosig Technologies (NASDAQ:STEX) Head to Head Survey
Bioventus Q4 Earnings Call Highlights
Bioventus (NASDAQ:BVS) Shares Gap Up After Analyst Upgrade
Bioventus Inc. (BVS) Q4 2025 Earnings Call Transcript
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
Reviewing Nanovibronix (NASDAQ:FEED) and Bioventus (NASDAQ:BVS)
Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medifocus (OTCMKTS:MDFZF) versus Bioventus (NYSE:BVS) Head-To-Head Comparison
Bioventus (NYSE:BVS) Trading Down 1.1% – Time to Sell?
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
Bioventus Inc. (BVS) Q3 2025 Earnings Call Transcript
Bioventus Reports Third Quarter Financial Results
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
Bioventus Inc. (BVS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
Bioventus Inc. (BVS) Q2 2025 Earnings Call Transcript
Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates
Bioventus Reports Second Quarter Financial Results
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates
Bioventus Reports First Quarter Financial Results
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
4 Healthcare Stocks to Buy as the Sector Faces Government Heat
Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now
Bioventus (BVS) Upgraded to Buy: Here's What You Should Know
Bioventus Inc. (BVS) Q4 2024 Earnings Call Transcript
Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million